Risk factors for cardiopulmonary and respiratory arrest in medical and surgical hospital patients on opioid analgesics and sedatives

Igor Izrailtyan, Jiejing Qiu, Frank J Overdyk, Mary Erslon, Tong J Gan, Igor Izrailtyan, Jiejing Qiu, Frank J Overdyk, Mary Erslon, Tong J Gan

Abstract

Background: Opioid induced respiratory depression is a known cause of preventable death in hospitals. Medications with sedative properties additionally potentiate opioid-induced respiratory and sedative effects, thereby elevating the risk for adverse events. The goal of this study was to determine what specific factors increase the risk of in-hospital cardiopulmonary and respiratory arrest (CPRA) in medical and surgical patients on opioid and sedative therapy.

Methods: The present study analyzed 14,504,809 medical inpatient and 6,771,882 surgical inpatient discharges reported into the Premier database from 2008 to 2012. Patients were divided in four categories: on opioids; on sedatives; on both opioids and sedatives; and on neither opioids nor sedatives.

Results: During hospital admission, 57% of all medical patients and 90% of all surgical patients were prescribed opioids, sedatives, or both. Surgical patients had a higher incidence of CPRA than medical patients (6.17 vs. 3.77 events per 1000 admissions; Relative Risk: 1.64 [95%CI: 1.62-1.66; p<0.0001). Opioids and sedatives were found to be independent predictors of CPRA (adjusted OR of 2.24 [95%CI: 2.18-2.29] for opioids and adjusted OR 1.80 [95%CI: 1.75-1.85] for sedatives in medical patients, and adjusted OR of 1.12 [95%CI: 1.07-1.16] for opioids and adjusted OR of 1.58 [95%CI: 1.51-1.66] for sedatives in surgical patients), with the highest risk in groups who received both types of medications (adjusted OR of 3.83 [95% CI: 3.74-3.92] in medical patients, and adjusted OR of 2.34 [95% CI: 2.25-2.42] in surgical patients) compared with groups that received neither type of medication. The common risk factors of CPRA in medical and surgical patients receiving both opioids and sedatives were Hispanic origin, mild liver disease, obesity, and COPD. Additionally, medical and surgical groups had their own unique risk factors for CPRA when placed on opioid and sedative therapy.

Conclusions: Opioids and sedatives are independent and additive predictors of CPRA in both medical and surgical patients. Receiving both classes of medications further exacerbates the risk of CPRA for these patients. By identifying groups at risk among medical and surgical in-hospital patients, this study provides a step towards improving our understanding of how to use opioid and sedative medications safely, which may influence our treatment strategies and outcomes. More precise monitoring of selected high-risk patients may help prevent catastrophic cardiorespiratory complications from these medications. As a retrospective administrative database analysis, this study does not establish the causality or the temporality of the events but rather draws statistically significant associations between the clinical factors and outcomes.

Conflict of interest statement

Competing Interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: This analysis was supported by Medtronic Healthcare Economics and Outcomes Research. JQ and ME are Medtronic employees. II and TJG received grant support for this study. FJO reports grant support and honorarium from Medtronic, unrelated to the submitted work. There are no patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.

References

    1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, et al. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation. 2015;131(4):e29–322. doi:
    1. Atwood C, Eisenberg MS, Herlitz J, Rea TD. Incidence of EMS-treated out-of-hospital cardiac arrest in Europe. Resuscitation. 2005;67(1):75–80. doi:
    1. Merchant RM, Yang L, Becker LB, Berg RA, Nadkarni V, Nichol G, et al. Incidence of treated cardiac arrest in hospitalized patients in the United States. Critical care medicine. 2011;39(11):2401–6. doi:
    1. Kronick SL, Kurz MC, Lin S, Edelson DP, Berg RA, Billi JE, et al. Part 4: Systems of Care and Continuous Quality Improvement: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. Circulation. 2015;132(18 Suppl 2):S397–413.
    1. Morrison LJ, Neumar RW, Zimmerman JL, Link MS, Newby LK, McMullan PW Jr., et al. Strategies for improving survival after in-hospital cardiac arrest in the United States: 2013 consensus recommendations: a consensus statement from the American Heart Association. Circulation. 2013;127(14):1538–63. doi:
    1. Nolan J. Commentary: IHCA: Catching up with Advances Made in Out-Of-Hospital Cardiac Arrest 2013 [updated 2014 Aug 5].
    1. The Joint Comission. Safe use of opioids in hospitals. Sentinel Event Alert: 2012 Aug 8. Report No.: Issue 49.
    1. Lee LA, Caplan RA, Stephens LS, Posner KL, Terman GW, Voepel-Lewis T, et al. Postoperative opioid-induced respiratory depression: a closed claims analysis. Anesthesiology. 2015;122(3):659–65. doi:
    1. Fecho K, Jackson F, Smith F, Overdyk FJ. In-hospital resuscitation: opioids and other factors influencing survival. Therapeutics and clinical risk management. 2009;5:961–8.
    1. Overdyk FJ, Guerra JJ. Improving outcomes in med-surg patients with opioid-induced respiratory depression. American Nurse Today. 2011;6(11):26–31.
    1. Carlisle H. The case for capnography in patients receiving opioids. American Nurse Today. 2014;9(9):22–7.
    1. Chen LH, Hedegaard H, Warner M. Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999–2011. NCHS Data Brief. 2014(166):1–8.
    1. Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016. MMWR Recomm Rep 2016;65(No. RR-1):1–49.
    1. Overdyk FJ, Dowling O, Marino J, Qiu J, Chien H-L, Erslon M, et al. Association of Opioids and Sedatives with Increased Risk of In-Hospital Cardiopulmonary Arrest from an Administrative Database. PLoS ONE. 2016;11(2):e0150214 doi:
    1. Overdyk FJ. Postoperative opioids remain a serious patient safety threat. Anesthesiology. 2010;113(1):259–60; author reply 60–1. doi:
    1. Churpek MM, Yuen TC, Winslow C, Hall J, Edelson DP. Differences in vital signs between elderly and nonelderly patients prior to ward cardiac arrest. Critical care medicine. 2015;43(4):816–22. doi:
    1. Stokes ME, Ye X, Shah M, Mercaldi K, Reynolds MW, Rupnow MF, et al. Impact of bleeding-related complications and/or blood product transfusions on hospital costs in inpatient surgical patients. BMC health services research. 2011;11:135 doi:
    1. Hogan H, Healey F, Neale G, Thomson R, Vincent C, Black N. Preventable deaths due to problems in care in English acute hospitals: a retrospective case record review study. BMJ quality & safety. 2012;21(9):737–45.
    1. Sessler DI. Preventing respiratory depression. Anesthesiology. 2015;122(3):484–5. doi:
    1. Strategies to Improve Cardiac Arrest Survival: A Time to Act. Robert Graham MAM, and Schultz Andrea M., Editors; Committee on the Treatment of Cardiac Arrest: Current Status and Future Directions; Board on Health Sciences Policy; Institute of Medicine, editor. Washington, D.C.: The National Academy of Sciences Press; 2015.
    1. Frenk SM, Porter KS, Paulozzi LJ. Prescription Opioid Analgesic Use Among Adults: United States, 1999–2012. NCHS Data Brief. 2015(189):1–8.
    1. Substance Abuse and Mental Health Services Administration. Results from the 2013 National Survey on Drug Use and Health: Summary of National Findings. 2013 Sep 16. Report No.: Pub id: SMA14-4863.
    1. National Center for Health Statistics. Health, United States, 2014: With Special Feature on Adults Aged 55–64, table 55. Hyattsville, MD 2014. 473 p.
    1. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in AdultsA Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Journal of the American College of Cardiology. 2014;63(25_PA).
    1. Rose DK, Cohen MM, Wigglesworth DF, DeBoer DP. Critical respiratory events in the postanesthesia care unit. Patient, surgical, and anesthetic factors. Anesthesiology. 1994;81(2):410–8.
    1. Chung SA, Yuan H, Chung F. A systemic review of obstructive sleep apnea and its implications for anesthesiologists. Anesthesia and analgesia. 2008;107(5):1543–63. doi:
    1. Practice Guidelines for the Perioperative Management of Patients with Obstructive Sleep Apnea. An Updated Report by the American Society of Anesthesiologists Task Force on Perioperative Management of Patients with Obstructive Sleep Apnea. Anesthesiology. 2014;120(2):268–86. doi:
    1. Practice Guidelines for the Prevention, Detection, and Management of Respiratory Depression Associated with Neuraxial Opioid Administration. An Updated Report by the American Society of Anesthesiologists Task Force on Neuraxial Opioids and the American Society of Regional Anesthesia and Pain Medicine. Anesthesiology. 2016;124(3):535–52. doi:
    1. Stone AA, Broderick JE. Obesity and Pain Are Associated in the United States. Obesity. 2012;20(7):1491–5. doi:
    1. Karlsson HK, Tuominen L, Tuulari JJ, Hirvonen J, Parkkola R, Helin S, et al. Obesity is associated with decreased mu-opioid but unaltered dopamine D2 receptor availability in the brain. The Journal of neuroscience: the official journal of the Society for Neuroscience. 2015;35(9):3959–65.
    1. De Baerdemaeker LE, Mortier EP, Struys MM. Pharmacokinetics in obese patients. Continuing Education in Anaesthesia, Critical Care & Pain. 2004;4(5):152–5.
    1. Mokhlesi B, Kryger MH, Grunstein RR. Assessment and Management of Patients with Obesity Hypoventilation Syndrome. Proceedings of the American Thoracic Society. 2008;5(2):218–25. doi:
    1. Verbeeck RK. Pharmacokinetics and dosage adjustment in patients with hepatic dysfunction. European journal of clinical pharmacology. 2008;64(12):1147–61. doi:
    1. Lee SS, Liu H. Cardiovascular determinants of survival in cirrhosis. Gut. 2007;56(6):746–8. doi:
    1. Zedler B, Xie L, Wang L, Joyce A, Vick C, Brigham J, et al. Development of a Risk Index for Serious Prescription Opioid-Induced Respiratory Depression or Overdose in Veterans' Health Administration Patients. Pain Medicine. 2015;16(8):1566–79. doi:
    1. Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. The Lancet. 2007;370(9589):765–73.
    1. World Health Organization. Community management of opioid overdose. 2014. 88p.
    1. Jarzyna D, Jungquist CR, Pasero C, Willens JS, Nisbet A, Oakes L, et al. American Society for Pain Management Nursing guidelines on monitoring for opioid-induced sedation and respiratory depression. Pain management nursing: official journal of the American Society of Pain Management Nurses. 2011;12(3):118–45.e10.
    1. Ekstrom MP, Bornefalk-Hermansson A, Abernethy AP, Currow DC. Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study. BMJ (Clinical research ed). 2014;348:g445.
    1. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. The New England journal of medicine. 1994;330(6):377–81. doi:
    1. Kessler ER, Shah M, Gruschkus SK, Raju A. Cost and quality implications of opioid-based postsurgical pain control using administrative claims data from a large health system: opioid-related adverse events and their impact on clinical and economic outcomes. Pharmacotherapy. 2013;33(4):383–91. doi:
    1. Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesthesia and intensive care. 2011;39(5):804–23.
    1. Korc-Grodzicki B, Downey RJ, Shahrokni A, Kingham TP, Patel SG, Audisio RA. Surgical considerations in older adults with cancer. Journal of clinical oncology: official journal of the American Society of Clinical Oncology. 2014;32(24):2647–53.
    1. Vinik AI, Erbas T, Casellini CM. Diabetic cardiac autonomic neuropathy, inflammation and cardiovascular disease. Journal of diabetes investigation. 2013;4(1):4–18. doi:
    1. Punjabi NM. Do sleep disorders and associated treatments impact glucose metabolism? Drugs. 2009;69 Suppl 2:13–27.
    1. Sobotka PA, Liss HP, Vinik AI. Impaired hypoxic ventilatory drive in diabetic patients with autonomic neuropathy. The Journal of clinical endocrinology and metabolism. 1986;62(4):658–63. doi:
    1. Geerlings SE, Hoepelman AI. Immune dysfunction in patients with diabetes mellitus (DM). FEMS immunology and medical microbiology. 1999;26(3–4):259–65.
    1. Brack A, Rittner HL, Stein C. Immunosuppressive effects of opioids—clinical relevance. Journal of neuroimmune pharmacology: the official journal of the Society on NeuroImmune Pharmacology. 2011;6(4):490–502.
    1. Huizinga MM, Peltier A. Painful Diabetic Neuropathy: A Management-Centered Review. Clinical Diabetes. 2007;25(1):6–15.
    1. Fala L, Welz JA. New Perspectives in the Treatment of Opioid-Induced Respiratory Depression. American health & drug benefits. 2015;8(6 Suppl 3):S51–63.
    1. Ibrahim AM, Hughes TG, Thumma JR, Dimick JB. Association of Hospital Critical Access Status With Surgical Outcomes and Expenditures Among Medicare Beneficiaries. Jama. 2016;315(19):2095–103. doi:
    1. Kolte D, Khera S, Aronow WS, Palaniswamy C, Mujib M, Ahn C, et al. Regional variation in the incidence and outcomes of in-hospital cardiac arrest in the United States. Circulation. 2015;131(16):1415–25. doi:
    1. Anderson ML, Nichol G, Dai D, Chan PS, Thomas L, Al-Khatib SM, et al. Association Between Hospital Process Composite Performance and Patient Outcomes After In-Hospital Cardiac Arrest Care. JAMA cardiology. 2016;1(1):37–45. doi:
    1. Makadia R, Ryan PB. Transforming the Premier Perspective Hospital Database into the Observational Medical Outcomes Partnership (OMOP) Common Data Model. EGEMS (Washington, DC). 2014;2(1):1–10.

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren